Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jost Hillenkamp

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
The British Journal of Ophthalmology|December 17, 2011
Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhageFelix Treumer, Johann Roider, Jost Hillenkamp
Ocular Immunology and Inflammation|October 12, 2010
Bilateral posterior scleritis: an idiopathic painless presentationParykshit Saikia, Ahmed Nashed, Horst Helbig, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 23, 2014
Hyperthermia-induced upregulation of vascular endothelial growth factor in retinal pigment epithelial cells is regulated by mitogen-activated protein kinasesHendrik Faby, Jost Hillenkamp, Johann Roider, et al.
Investigative Ophthalmology & Visual Science|April 26, 2003
Human retinal molecular weight exclusion limit and estimate of species variationTimothy L Jackson, Richard J Antcliff, Jost Hillenkamp, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 26, 2023
The Role of Preoperative Case Selection in the Training of Surgical Repair of Primary Rhegmatogenous Retinal DetachmentAntony William, Sophia Kuehnel, Spyridon Dimopoulos, et al.
The British Journal of Ophthalmology|March 6, 2015
Compatibility of recombinant tissue plasminogen activator (rtPA) and aflibercept or ranibizumab coapplied for neovascular age-related macular degeneration with submacular haemorrhageAlexa Klettner, Simon Grotelüschen, Felix Treumer, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 25, 2012
Complication rate and risk factors for intraoperative complications in resident-performed phacoemulsification surgeryAndrea Briszi, Philipp Prahs, Jost Hillenkamp, et al.
JMM Case Reports|December 1, 2017
Postoperative <i>Tropheryma whipplei</i> endophthalmitis - a case report highlighting the additive value of molecular testingJulia Dick, Patrizia Krauß, Jost Hillenkamp, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 14, 2012
Compatibility of recombinant tissue plasminogen activator and bevacizumab co-applied for neovascular age-related macular degeneration with submacular hemorrhageAlexa Klettner, Svenja Puls, Felix Treumer, et al.
Die Ophthalmologie|June 20, 2023
[Analysis of adverse drug reactions (ADR) in fluorescein angiography (FAG) and indocyanine green angiography (ICGA) and indications before and during the COVID-19 pandemic at a university eye hospital]Nikolai Kleefeldt, Anna Schneider, Sophia Kühnel, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
The British Journal of Ophthalmology|December 17, 2011
Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhageFelix Treumer, Johann Roider, Jost Hillenkamp
Ocular Immunology and Inflammation|October 12, 2010
Bilateral posterior scleritis: an idiopathic painless presentationParykshit Saikia, Ahmed Nashed, Horst Helbig, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 23, 2014
Hyperthermia-induced upregulation of vascular endothelial growth factor in retinal pigment epithelial cells is regulated by mitogen-activated protein kinasesHendrik Faby, Jost Hillenkamp, Johann Roider, et al.
Investigative Ophthalmology & Visual Science|April 26, 2003
Human retinal molecular weight exclusion limit and estimate of species variationTimothy L Jackson, Richard J Antcliff, Jost Hillenkamp, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 26, 2023
The Role of Preoperative Case Selection in the Training of Surgical Repair of Primary Rhegmatogenous Retinal DetachmentAntony William, Sophia Kuehnel, Spyridon Dimopoulos, et al.
The British Journal of Ophthalmology|March 6, 2015
Compatibility of recombinant tissue plasminogen activator (rtPA) and aflibercept or ranibizumab coapplied for neovascular age-related macular degeneration with submacular haemorrhageAlexa Klettner, Simon Grotelüschen, Felix Treumer, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 25, 2012
Complication rate and risk factors for intraoperative complications in resident-performed phacoemulsification surgeryAndrea Briszi, Philipp Prahs, Jost Hillenkamp, et al.
JMM Case Reports|December 1, 2017
Postoperative <i>Tropheryma whipplei</i> endophthalmitis - a case report highlighting the additive value of molecular testingJulia Dick, Patrizia Krauß, Jost Hillenkamp, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 14, 2012
Compatibility of recombinant tissue plasminogen activator and bevacizumab co-applied for neovascular age-related macular degeneration with submacular hemorrhageAlexa Klettner, Svenja Puls, Felix Treumer, et al.
Die Ophthalmologie|June 20, 2023
[Analysis of adverse drug reactions (ADR) in fluorescein angiography (FAG) and indocyanine green angiography (ICGA) and indications before and during the COVID-19 pandemic at a university eye hospital]Nikolai Kleefeldt, Anna Schneider, Sophia Kühnel, et al.
Pageof 9